PATHOLOGICAL-CHANGES IN THE LONG-TERM TRANSPLANTED HEART - A MORPHOMETRIC STUDY OF MYOCARDIAL HYPERTROPHY, VASCULARITY, AND FIBROSIS

被引:48
|
作者
ROWAN, RA
BILLINGHAM, ME
机构
[1] Department of Pathology, Stanford University School of Medicine, Stanford, CA
关键词
endomyocardial biopsies; light and electron microscopic morphometry;
D O I
10.1016/0046-8177(90)90037-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Myocyte hypertrophy and myocardial fibrosis have been observed in transplanted human hearts, and both could potentially have an adverse effect on long-term cardiac function. There has been some concern that distant donor heart procurement and cyclosporine treatment increase the risk of these changes, but their incidence and severity have not been documented quantitatively in large numbers of cardiac transplant recipients. We used light microscopic morphometric methods to estimate myocardial collagen volume fraction and myocyte width in right ventricular endomyocardial biopsies from 95 recipients at 3 years posttransplantation, and electron microscopic stereology to estimate myocardial vascularity and myocyte myofibril content in 40 recipients, also at 3 years posttransplantation. We compared those with locally and distantly procured donor hearts (mean ischemic time 160 minutes) and cyclosporine versus noncyclosporine immunosuppression. Controls were pretransplant right ventricular biopsies from 20 donor hearts which were free of heart disease. We found no significant differences in myocardial collagen volume fractions. Myocyte hypertrophy was typical of all the transplant biopsies (mean myocyte width 20.2 μm, SD 3.0 in all transplants versus 11.8 μm, SD 2.2 in controls, P < 0.001), but distant donor procurement and cyclosporine had no significant effect. There were significant reductions of myofibril volume fraction in the transplants, which raises the possibility of gradual decompensation in some patients. There were no significant differences in myocardial vascularity, although a few patients were well below the control range. We conclude that distant donor heart procurement, with ischemic times averaging less than 3 hours, and cyclosporine treatment are not responsible for significant hypertrophy or fibrosis in most transplants. Hypertrophy is typical of the transplanted heart, and it is possible that associated abnormalities might have an effect on cardiac function in some long-term survivors. © 1990.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 50 条
  • [31] Heart pathomorphological changes in the long-term alcohol consumption
    Tertyshnyi, S., I
    Shuliatnikova, T., V
    Zubko, M. D.
    PATHOLOGIA, 2020, (02): : 149 - 155
  • [32] Menopause changes the long-term heart rate variability
    Banach, T
    Dobrek, L
    Furgala, A
    Kolasinska-Kloch, W
    Thor, PJ
    Progress in Coronary Artery Disease, 2005, : 85 - 88
  • [33] Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by β-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis
    Pacca, SRMC
    de Azevedo, AP
    De Oliveira, CF
    De Luca, IMS
    De Nucci, G
    Antunes, E
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (02) : 201 - 207
  • [34] Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: the Rotterdam Study
    Leening, Maarten J. G.
    Elias-Smale, Suzette E.
    Felix, Janine F.
    Kors, Jan A.
    Deckers, Jaap W.
    Hofman, Albert
    Stricker, Bruno H. Ch
    Witteman, Jacqueline C. M.
    HEART, 2010, 96 (18) : 1458 - 1462
  • [35] LONG-TERM THERAPY WITH DEFLAZACORT DECREASES MYOCARDIAL FIBROSIS IN mdx MICE
    Marques, Maria Julia
    Oggiam, Daniella Silva
    Chagas Barbin, Isabel Cristina
    Ferretti, Renato
    Santo Neto, Humberto
    MUSCLE & NERVE, 2009, 40 (03) : 466 - 468
  • [36] Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy
    Senra, Tiago
    Ianni, Barbara M.
    Costa, Ana C. P.
    Mady, Charles
    Martinelli-Filho, Martino
    Kalil-Filho, Roberto
    Rochitte, Carlos E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (21) : 2577 - 2587
  • [37] Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes
    Ares-Carrasco, S.
    Picatoste, B.
    Benito-Martin, A.
    Zubiri, I.
    Sanz, A. B.
    Sanchez-Nino, M. D.
    Ortiz, A.
    Egido, J.
    Tunon, J.
    Lorenzo, O.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (06): : H2109 - H2119
  • [38] Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure A Cardiovascular Magnetic Resonance Study
    Gulati, Ankur
    Japp, Alan G.
    Raza, Sadaf
    Halliday, Brian P.
    Jones, Daniel A.
    Newsome, Simon
    Ismail, Nizar A.
    Morarji, Kishen
    Khwaja, Jahanzaib
    Spath, Nick
    Shakespeare, Carl
    Kalra, Paul R.
    Lloyd, Guy
    Mathur, Anthony
    Cleland, John G. F.
    Cowie, Martin R.
    Assomull, Ravi G.
    Pennell, Dudley J.
    Ismail, Tevfik F.
    Prasad, Sanjay K.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2018, 11 (09) : e007722
  • [39] Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI
    Guzman, Raphael
    Uchida, Nobuko
    Bliss, Tonya M.
    He, Dongping
    Christopherson, Karen K.
    Stellwagen, David
    Capela, Alexandra
    Greve, Joan
    Malenka, Robert C.
    Moseley, Michael E.
    Palmer, Theo D.
    Steinberg, Gary K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) : 10211 - 10216
  • [40] Ultrastructural changes during myocardial hypertrophy and its regression: Long-term effects of nifedipine in adult spontaneously hypertensive rats
    Toshiyuki Kimpara
    Makoto Okabe
    Hikaru Nishimura
    Tetsuya Hayashi
    Kikuko Imamura
    Keishiro Kawamura
    Heart and Vessels, 1997, 12 : 143 - 151